These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. Brouwer RM; Bolli P; Erné P; Conen D; Kiowski W; Bühler FR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S88-91. PubMed ID: 2580183 [TBL] [Abstract][Full Text] [Related]
7. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984. J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378 [No Abstract] [Full Text] [Related]
8. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Karasawa A; Kubo K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients. Franz IW; Wiewel D J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363 [TBL] [Abstract][Full Text] [Related]
10. [Indications for calcium channel antagonist therapy according to the latest large clinical trials]. Kosicka T; Kara-Perz H; Głuszek J; Perz S Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496 [No Abstract] [Full Text] [Related]
11. Calcium-entry blocking agents in the treatment of systemic hypertension. Robinson BF Am J Cardiol; 1985 Jan; 55(3):102B-106B. PubMed ID: 2857516 [TBL] [Abstract][Full Text] [Related]
12. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
13. [Verapamil and nitrendipine in beta blocker-resistant hypertensive patients]. Edmonds D; Förster E; Wehling M; Siegenthaler W; Vetter W Schweiz Rundsch Med Prax; 1985 May; 74(19):510-3. PubMed ID: 3160098 [No Abstract] [Full Text] [Related]
16. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
17. [Nitrendipine, a new calcium antagonist, in the therapy of arterial hypertension]. Cosmi F; Mollaioli M; Aimi M; Conti G; Corbacelli C; Bianco C; Ricca M Minerva Med; 1985 Nov; 76(42):1983-90. PubMed ID: 2933597 [TBL] [Abstract][Full Text] [Related]
18. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension]. Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740 [TBL] [Abstract][Full Text] [Related]
19. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ; JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465 [TBL] [Abstract][Full Text] [Related]
20. [Calcium antagonists in the treatment of arterial hypertension]. Kuznetsov VN Klin Med (Mosk); 1985 Nov; 63(11):9-15. PubMed ID: 2868150 [No Abstract] [Full Text] [Related] [Next] [New Search]